Safety and efficacy study on etanercept in patients with plaque psoriasis [11]

British Journal of Dermatology

Volumn 152, Issue 1, 2005, Pages 187-189

  Costanzo, A ^a   Mazzotta, A ^a   Papoutsaki, M ^a   Nistico S ^a   Chimenti, S ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; ETANERCEPT; METHOTREXATE; RETINOID; TUMOR NECROSIS FACTOR;

ADULT; BODY SURFACE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; INJECTION SITE; LETTER; MALE; OPEN STUDY; PRIORITY JOURNAL; PSORIASIS VULGARIS; SIDE EFFECT; SKIN MANIFESTATION; TREATMENT OUTCOME; URTICARIA; AGED; CLINICAL ASSESSMENT; DRUG TOLERANCE; DRUG WITHDRAWAL; LABORATORY TEST; MONOTHERAPY; PSORIASIS AREA AND SEVERITY INDEX; PSORIATIC ARTHRITIS; RATING SCALE; RHEUMATOID ARTHRITIS;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 13244284841     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06306.x     Document Type: Letter

References (8)

1. Goldenberg MM. Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis. Clin Ther 1999; 21:75-87.
2. Goffe B, Cather JC. Etanercept: an overview. J Am Acad Dermatol 2003; 49 (Suppl. 2):S105-11.
3. Moreland LW. Inhibitors of tumor necrosis factor for rheumatoid arthritis. J Rheumatol 1999; 26 (Suppl. 57):7-15.
4. Krueger G, Callis K. Potential of tumor necrosis factor inhibitors in psoriasis and psoriatic arthritis. Arch Dermatol 2004; 140:218-25.
5. Ruderman EM. Evaluation and management of psoriatic arthritis: the role of biologic therapy. J Am Acad Dermatol 2003; 49 (Suppl. 2):S125-32.
6. Leonardi CL, Powers JL, Matheson RT et al. Etanercept as monotherapy in patients with psoriasis. N Engl J Med 2003; 349:2014-22.
7. Gottlieb AB, Matheson RT, Lowe N et al. A randomized trial of etanercept as monotherapy for psoriasis. Arch Dermatol 2003; 139:1627-32.
8. Ritchie DM, Boyle JA, McInnes JM et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968; 37:393-406.